10-Q Filing

BNB PLUS CORP. CIK: 744452 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001104659-21-020663`
Period End Date	20201231
Filing Date	20210211
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	apdn-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 37 Cash Flow Statement 61 Stockholders Equity 19

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$11.97K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$11.97K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.79M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $11,968 at December 31, 2020 and September 30, 2020, respectively	`AccountsReceivableNetCurrent`	$1.03M	USD	Point-in-time
Accounts receivable, net of allowance of $11,968 at December 31, 2020 and September 30, 2020, respectively	`AccountsReceivableNetCurrent`	$194.32K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$543.46K	USD	Point-in-time
Inventories	`InventoryNet`	$497.37K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$599.30K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$721.15K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$9.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.66M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.17M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.14M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.28M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.66M	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.05K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.08K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Goodwill	`Goodwill`	$285.39K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$605.33K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$582.34K	USD	Point-in-time
Total Assets	`Assets`	$11.34M	USD	Point-in-time
Total Assets	`Assets`	$9.68M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.90M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.93M	USD	Point-in-time
Promissory notes payable-current portion	`NotesPayableToBankCurrent`	$658.61K	USD	Point-in-time
Promissory notes payable-current portion	`NotesPayableToBankCurrent`	$329.30K	USD	Point-in-time
Secured convertible notes payable , net of debt issuance costs	`ConvertibleNotesPayableCurrent`	$1.50M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$364.83K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$511.04K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.92M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$848.31K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$848.31K	USD	Point-in-time
Promissory notes payable-long term portion	`NotesPayableToBankNoncurrent`	$188.18K	USD	Point-in-time
Promissory notes payable-long term portion	`NotesPayableToBankNoncurrent`	$517.49K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.95M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.63M	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note H)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2020 and September 30, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2020 and September 30, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2020 and September 30, 2020, 5,661,330 and 5,142,779 shares issued and outstanding as of December 31 2020 and September 30, 2020, respectively	`CommonStockValue`	$5.66K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2020 and September 30, 2020, 5,661,330 and 5,142,779 shares issued and outstanding as of December 31 2020 and September 30, 2020, respectively	`CommonStockValue`	$5.14K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$280.37M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$275.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-269.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-274.65M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$5.73M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$5.72M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-8.72K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-6.23K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$11.34M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$9.68M	USD	Point-in-time

Income Statement 37 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.62M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$633.52K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$242.56K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$232.03K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.50M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.37M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$564.43K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$748.37K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$97.41K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$75.07K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.35M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.97M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.61M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-29.09K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-5.44K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-22.23K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-53.86K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.66M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.81M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-2.66M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-4.81M	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-30.00	USD	1 Quarter
Less: Net (income) loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.49K	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-4.81M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-2.66M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$-2.84K	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.67M	USD	1 Quarter
NET LOSS applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.81M	USD	1 Quarter
Net loss per share applicable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.88	USD	1 Quarter
Net loss per share applicable to common stockholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.12	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.46M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.38M	shares	1 Quarter

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$97.41K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$75.07K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$205.49K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$571.50K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$6.16K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$840.03K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-565.98K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$46.10K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-59.95K	USD	1 Quarter
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$121.85K	USD	1 Quarter
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.34K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-638.07K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-793.89K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-146.21K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-173.94K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.16M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.73M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$329.54K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-329.54K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Repayment of secured convertible notes payable	`RepaymentsOfConvertibleDebt`	$1.67M	USD	1 Quarter
Repayment of secured convertible notes payable	`RepaymentsOfConvertibleDebt`	$107.80K	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.61M	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.10M	USD	Point-in-time
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	-	USD	1 Quarter
Net proceeds from sale of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$10.94M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$939.95K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.84M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.55M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.10M	USD	1 Quarter
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.24M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.24M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$558.99K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.66M	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest paid in kind	`PaidInKindInterest`	$35.24K	USD	1 Quarter
Interest paid in kind	`PaidInKindInterest`	$35.62K	USD	1 Quarter
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$641.98K	USD	1 Quarter
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	-	USD	1 Quarter
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	$2.84K	USD	1 Quarter
Deemed dividend-warrant repricing	`DeemedDividendWarrantRepricing`	-	USD	1 Quarter
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	$109.70K	USD	1 Quarter
Deferred offering costs reclassified to additional paid in capital	`ReclassificationOfDeferredOfferingCostToAdditionalPaidInCapital`	-	USD	1 Quarter
Public offering costs included in accounts payable and accrued liabilities	`OfferingCostsIncurredAndIncludedInAccountsPayable`	$303.21K	USD	1 Quarter
Public offering costs included in accounts payable and accrued liabilities	`OfferingCostsIncurredAndIncludedInAccountsPayable`	-	USD	1 Quarter
FV of warrants issued	`FairValueOfWarrantsIssued`	-	USD	1 Quarter
FV of warrants issued	`FairValueOfWarrantsIssued`	$1.07M	USD	1 Quarter

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.66M	shares	Point-in-time
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-10.53M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$-2.61M	USD	1 Quarter
Fair value of warrants issued in connection with convertible note repayment	`WarrantsIssuedDuringPeriodValueWarrants`	$1.64M	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$571.50K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$205.49K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.66M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.22M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-848.50K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	5.66M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.